Paul J Bröckelmann

27PUBLICATIONS
106CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesGene and molecular therapyBiomechanicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 10, 2026
Brentuximab Vedotin after AlloSCT for Relapsed/Refractory Hodgkin Lymphoma: GHSG BV-ALLO Phase II Trial.

|Apr 02, 2026
Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.

Anne Sophie Robertz, Ina Bühnen, Julia Meissner

|Jan 27, 2026
Rapid molecular response kinetics to anti-PD-1-based first-line treatment of Hodgkin lymphoma in the GHSG NIVAHL trial.

Jan-Michel Heger, Julia Mattlener, Peter Herhaus

|Jan 26, 2026
Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model.

Claus-Moritz Gräf, Moritz Reese, Angela Vicente-Luque

|Dec 24, 2025
Four Months of Exercise Intervention Improved Visuomotor, Functional and Cardiorespiratory Capacity in a Patient with Metastatic Uveal Melanoma.

Michael Mendes Wefelnberg, Stefanie Hennigfeld, Michael Simon

|Nov 01, 2025
Feasibility and safety of anti-PD1 first-line treatment of classic Hodgkin lymphoma: do we see the full picture?

Christian P Jaworek, Paul J Bröckelmann

Pageof 5

Frequent Collaborators

11 joint publications

Bastian von Tresckow

9 joint publications

Carsten Kobe

5 joint publications

Wolfram Klapper

4 joint publications

Dennis A Eichenauer